Boston, MA: Process & Analytical Development And Manufacturing Facility

The launch of our Process & Analytical Development and Manufacturing Facility signifies a strategic enhancement of our presence in the Boston area, focusing on our expertise in process and analytical development (PAD) alongside commercial drug substance manufacturing—all in one location.

Specializing in biologics, vaccines, nucleic acids, and gene therapy, the Boston facility is now commercially licensed and boasts a 10x 2,000L drug substance manufacturing capacity. By integrating technical capabilities with manufacturing, we can deliver life-changing therapies to patients more swiftly and efficiently.

As we enter this exciting new chapter, our commitment to excellence remains strong, and we look forward to continued growth and success in Boston.